clarithromycin has been researched along with hmr 3647 in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.82) | 18.2507 |
2000's | 20 (36.36) | 29.6817 |
2010's | 31 (56.36) | 24.3611 |
2020's | 3 (5.45) | 2.80 |
Authors | Studies |
---|---|
Agouridas, C; Auger, JM; Benedetti, Y; Bonnefoy, A; Bretin, F; Chantot, JF; D'Ambrières, SG; Denis, A; Dussarat, A; Fromentin, C; Lachaud, S; Laurin, P; Le Martret, O; Loyau, V; Pejac, JM; Perron, S; Tessot, N | 1 |
Agouridas, C; Bonnefoy, A; Bonnet, A; Bretin, F; Denis, A; Fromentin, C; Piltan, G | 1 |
Alder, J; Brazzale, A; Cao, Z; Chu, DT; Clark, RF; Ewing, P; Flamm, R; Griesgraber, G; Li, L; Ma, Z; Meulbroek, J; Mitten, M; Nemoto, PA; Nilius, AM; Or, YS; Phan, LT; Plattner, JJ; Rupp, MJ; Shortridge, VD; Wang, S; Yong, H; Zhang, S; Zhang, X; Zhong, P | 1 |
Anderson, S; Barker, L; Burger, MT; Carroll, GL; Chu, DT; Desai, MC; Hiebert, C; Huh, K; Kidney, J; Langhorne, M; Lin, X; Plattner, JJ; Rico, AC; Seid, M; Shawar, R; Young, K | 1 |
Barker, L; Carroll, GL; Chu, DT; Desai, MC; Lin, X; Plattner, JJ; Rico, AC; Shawar, R | 1 |
Klugman, KP; Low, DE; Smith, AM; Wolter, N | 1 |
Aralar, P; Baimukanova, G; Bermudez, LE; Chee, C; Inderlied, C; Kolonoski, P; Motamedi, N; Phan, LT; Wang, G; Young, LS | 1 |
Baba, S; Billal, DS; Fujihara, K; Hotomi, M; Nishimura, T; Suzuki, K; Yamanaka, N | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K | 1 |
Chiba, N; Hasegawa, K; Iwata, S; Matsubara, K; Morozumi, M; Nakayama, E; Sunakawa, K; Takayanagi, R; Ubukata, K | 1 |
Douthwaite, S; Farrell, DJ; Klugman, KP; Northwood, JB; Smith, AM; Wolter, N | 1 |
Bailey, M; Chettiath, T; Mankin, AS | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Brown-Elliott, BA; Nash, KA; Wallace, RJ | 1 |
Jiang, LJ; Or, YS; Wang, M | 1 |
Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P | 1 |
Chen, XZ; Jin, ZP; Lei, PS; Li, Y; Liu, J; Liu, L; Wang, GQ; Xu, P | 1 |
Lemaire, S; Tulkens, PM; Van Bambeke, F | 1 |
Amaral, K; Dzink-Fox, J; Fischer, E; Goldovitz, J; Manni, K; Neckermann, G; Osborne, CS; Pecanka, R; Ryder, NS; Yu, D | 1 |
Buzon, RA; Chupak, L; Dougherty, TJ; Falcone, MJ; Farley, KA; Finegan, SM; Flanagan, ME; Girard, D; Granskog, K; Hagen, AE; Hardink, JR; Huband, MD; Kamicker, BJ; Kaneko, T; Knickerbocker, MJ; Li, B; Liras, JL; Magee, TV; Marra, A; Medina, I; Nguyen, TT; Noe, MC; O'Donnell, JP; Obach, RS; Penzien, JB; Reilly, UD; Ripp, SL; Schafer, JR; Shen, Y; Stone, GG; Strelevitz, TJ; Sun, J; Tait-Kamradt, A; Vaz, AD; Whipple, DA; Widlicka, DW; Wishka, DG; Wolkowski, JP | 1 |
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, KM; McGhee, P; Nagai, K | 1 |
Furuie, H; Saisho, Y; Shimada, J; Yoshikawa, T | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Hammerschlag, MR; Kohlhoff, SA; Parker, C; Roblin, PM | 1 |
Castanheira, M; Jones, RN; Woosley, LN | 1 |
Shakya, T; Wright, GD | 1 |
Ajito, K; Fushimi, H; Kanemoto, K; Miura, T; Natsume, S; Shitara, E; Yoshida, T | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
Alihodzić, S; Andreotti, D; Berge, JM; Cipcić Paljetak, H; Derek, M; Dumić, M; Eraković Haber, V; Fajdetić, A; Holmes, DJ; Hutinec, A; Lazarevski, G; Lociuro, S; Marsić, N; Mutak, S; Spaventi, R; Stimac, V; Sunjić, V | 1 |
Biedenbach, DJ; Hammerschlag, MR; Jones, RN; Kohlhoff, SA; Roblin, PM | 1 |
Alihodzić, S; Antolović, R; Broskey, JP; Cipcić Paljetak, H; Eraković Haber, V; Holmes, DJ; Hunt, E; Jarvest, RL; Kapić, S | 1 |
Chen, XZ; Jin, ZP; Lei, PS; Liu, L; Xu, P | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, XZ; Lei, PS; Liu, L; Xu, P; Zheng, D | 1 |
Bhateja, P; Chakrabarti, A; Das, B; Dullu, J; Hajare, AK; Jadhav, JS; Kumar, R; Pandya, M; Ramkumar, G; Rathy, S; Surase, YB; Venkataramanan, R | 1 |
Sugimoto, T; Suzuki, K; Tanikawa, T; Yamasaki, Y | 1 |
Chen, X; Lei, P; Liu, L; Liu, Y; Xu, P; Xu, Y; Zhu, D | 1 |
An, K; Cushman, M; Li, XL; Liang, JH; Lv, W; Wang, H; Xu, YC | 1 |
Jiang, JW; Li, X; Nie, Y; Sun, HP; Sun, Y; You, QD; Zhang, XJ; Zhi, HJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, X; Jin, L; Lei, P; Liu, C; Liu, Y; Xu, Y; Zhao, Z; Zhu, D | 1 |
Chen, X; Lei, P; Liu, Y; Xu, Y; Zhao, Z; Zhu, D | 1 |
Cushman, M; Guo, SY; Han, X; Liang, JH; Lv, W | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kimmins, S; Mutak, S; Pavlović, D | 1 |
Cushman, M; Fan, BZ; Han, X; Li, YX; Liang, JH; Lv, W; Tian, JC; Wang, H | 1 |
Jin, LL; Lei, PS; Yang, S; Zhang, XX; Zhao, ZH | 1 |
Cushman, M; Fan, BZ; Han, X; Kong, FS; Li, YX; Liang, JH; Lv, W; Ma, CX; Tian, JC | 1 |
Cushman, M; Fan, BZ; Guo, SY; Kong, FS; Li, XM; Li, YX; Liang, JH; Lv, W; Zhang, J | 1 |
Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB | 1 |
Aldrich, C; Brody, S; Cushman, M; Fan, BZ; Hiasa, H; Liang, JH; Lv, W; Yang, ZY | 1 |
Cushman, M; Ding, J; Li, Y; Liang, JH; Liu, LY; Liu, XP; Lv, W; Xue, F; Zhang, JR; Zhang, JZ; Zhao, F | 1 |
1 review(s) available for clarithromycin and hmr 3647
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for clarithromycin and hmr 3647
Article | Year |
---|---|
Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Macrolides; Male; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Asian People; Bridged-Ring Compounds; Bronchoalveolar Lavage; Chromatography, High Pressure Liquid; Humans; Macrolides; Macrophages, Alveolar; Male; Mass Spectrometry; Middle Aged; Pulmonary Alveoli; Young Adult | 2010 |
52 other study(ies) available for clarithromycin and hmr 3647
Article | Year |
---|---|
Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Ketolides; Macrolides; Mice; Microbial Sensitivity Tests; Molecular Structure | 1999 |
Beta-keto-ester chemistry and ketolides. Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Macrolides; Mice; Structure-Activity Relationship | 2000 |
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cell-Free System; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Mice; Models, Molecular; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Respiratory Tract Infections; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Transcription, Genetic | 2001 |
Synthesis and antibacterial activity of novel C12 vinyl ketolides.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Enterococcus faecalis; Haemophilus Infections; Haemophilus influenzae; Half-Life; Ketolides; Lung Diseases; Male; Microbial Sensitivity Tests; Pneumococcal Infections; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Vinyl Compounds | 2006 |
Synthesis and antibacterial activity of C12 des-methyl ketolides.
Topics: Anti-Bacterial Agents; Carbon; Gram-Positive Cocci; Haemophilus influenzae; Ketolides; Methylation; Molecular Structure; Structure-Activity Relationship | 2006 |
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Bacterial; Genotype; Humans; Ketolides; Methyltransferases; Microbial Sensitivity Tests; Mutation; Phenotype; Pneumococcal Infections; Ribosomal Proteins; Streptococcus pneumoniae | 2007 |
EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.
Topics: Animals; Anti-Bacterial Agents; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Humans; Macrolides; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium | 2007 |
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.
Topics: Adolescent; Adult; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Female; Gene Frequency; Genotype; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Respiratory Tract Infections | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2007 |
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; RNA, Ribosomal, 23S | 2008 |
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.
Topics: 5' Untranslated Regions; Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Ketolides; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; RNA, Ribosomal; Sequence Deletion; Streptococcus pneumoniae | 2008 |
Induction of erm(C) expression by noninducing antibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enzyme Induction; Escherichia coli; Gene Expression Regulation, Bacterial; Ketolides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Conformation; Protein Sorting Signals; Ribosomes; RNA, Messenger | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
Topics: Amino Acid Sequence; Clarithromycin; Drug Resistance, Bacterial; Humans; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium chelonae; Nontuberculous Mycobacteria; Polymerase Chain Reaction; RNA | 2009 |
Comparative antipneumococcal activities of sulopenem and other drugs.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2009 |
Synthesis of novel macrolide derivatives with imidazo[4,5-b]pyridinyl sulfur contained alkyl side chains and their antibacterial activity.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Imidazoles; Ketolides; Macrolides; Microbial Sensitivity Tests; Models, Chemical; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Sulfides; Sulfur | 2009 |
Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.
Topics: Anti-Bacterial Agents; Cell Line; Humans; Ketolides; Legionella pneumophila; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus | 2009 |
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
Topics: Acetamides; Amidohydrolases; Animals; Anti-Infective Agents; Female; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Peptides; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh | 2009 |
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections.
Topics: Animals; Azetidines; Bacteria; Community-Acquired Infections; Disease Susceptibility; Drug Discovery; Drug Resistance, Multiple; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Mice; Microbial Sensitivity Tests; Respiratory Tract Infections | 2009 |
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila Infections; Chlamydophila pneumoniae; Female; Humans; Infant; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Triazoles | 2010 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Nucleotide selectivity of antibiotic kinases.
Topics: Anti-Bacterial Agents; Bacteria; Binding, Competitive; Drug Resistance, Bacterial; Guanosine Triphosphate; Kanamycin Kinase; Models, Chemical; Nucleotides; Phosphotransferases (Alcohol Group Acceptor); Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Substrate Specificity | 2010 |
Novel azalides derived from 16-membered macrolides. III. Azalides modified at the C-15 and 4'' positions: Improved antibacterial activities.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Indicators and Reagents; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
4''-O-(omega-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Propionates | 2010 |
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Fusidic Acid; Neisseria gonorrhoeae | 2010 |
6-Alkylquinolone-3-carboxylic acid tethered to macrolides synthesis and antimicrobial profile.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Macrolides; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship | 2010 |
A new series of macrolide derivatives with 4''-O-saccharide substituents.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Glycosylation; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Macrolides; Staphylococcus; Streptococcus | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis and antibacterial activity of novel ketolides with 11,12-sulfur contained aryl alkyl side chains.
Topics: Anti-Bacterial Agents; Bacteria; Ketolides; Microbial Sensitivity Tests; Sulfur | 2011 |
Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Models, Chemical; Nitrogen; Respiratory Tract Infections; Streptococcus pneumoniae | 2012 |
Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as '11a-azalides'.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2012 |
Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Ketolides; Microbial Sensitivity Tests; Molecular Conformation; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus Phages; Streptococcus pneumoniae; Structure-Activity Relationship | 2012 |
Synthesis and antibacterial activity of 9-oxime ether non-ketolides, and novel binding mode of alkylides with bacterial rRNA.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Ether; Ketolides; Models, Molecular; Oximes; RNA, Bacterial; RNA, Ribosomal | 2013 |
Synthesis and antibacterial evaluation of a novel series of 10-hydroxyl ketolide derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Clarithromycin; Crystallography, X-Ray; Drug Evaluation, Preclinical; Ketolides; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Conformation; Molecular Docking Simulation; Peptidyl Transferases; Protein Structure, Tertiary; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and antibacterial activity of novel modified 5-O-mycaminose 14-membered ketolides.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Ketolides; Methicillin; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2013 |
Synthesis of 4″-O-desosaminyl clarithromycin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Clarithromycin; Glycosylation; Macrolides; Microbial Sensitivity Tests; Structure-Activity Relationship | 2013 |
Synthesis and structure-activity relationships of novel 9-oxime acylides with improved bactericidal activity.
Topics: Anti-Bacterial Agents; Binding Sites; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Hydrogen Bonding; Ketolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Oximes; Ribosome Subunits, Large, Bacterial; Staphylococcus aureus; Streptococcus pyogenes; Structure-Activity Relationship | 2015 |
Synthesis of novel 15-membered 8a-azahomoerythromycin A acylides: Consequences of structural modification at the C-3 and C-6 position on antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Structure-Activity Relationship | 2017 |
Design, synthesis and structure-bactericidal activity relationships of novel 9-oxime ketolides and reductive epimers of acylides.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Ketolides; Molecular Docking Simulation; Oximes; Ribosomes; Stereoisomerism; Structure-Activity Relationship | 2017 |
Synthesis and antibacterial activity of novel ketolides with 11,12-quinoylalkyl side chains.
Topics: Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Haemophilus influenzae; Ketolides; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Staphylococcus; Structure-Activity Relationship | 2018 |
Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Ketolides; Microbial Sensitivity Tests; Molecular Structure; Oximes; Quinolones; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2019 |
Synthesis and structure-bactericidal activity relationships of non-ketolides: 9-Oxime clarithromycin 11,12-cyclic carbonate featured with three-to eight-atom-length spacers at 3-OH.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2019 |
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides | 2020 |
Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
Topics: Anti-Bacterial Agents; Azithromycin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |
Design and synthesis of novel macrolones bridged with linkers from 11,12-positions of macrolides.
Topics: Anti-Bacterial Agents; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Quinolones; Structure-Activity Relationship | 2022 |